Cybersecurity Emphasis Recent cyberattack and data breach highlight elevated risk to patient data and clinical trial information, creating demand for enhanced security operations, incident response, threat detection, and third-party risk management partnerships.

Data Privacy The company already leverages Snowflake and GDPR frameworks, presenting an opportunity to offer data governance, privacy-by-design, and regulatory-compliant analytics solutions to accelerate data-driven decision making while ensuring cross-border data protection.

Manufacturing Expansion Recent facility expansions in Tianjin and the growth of drug manufacturing and injection pen assembly capacity signal a need for process optimization, manufacturing execution systems, quality management, and supply chain resilience solutions.

AI Simulation With existing AI assets and usage of Ansys Fluent, Novo Nordisk could benefit from advanced analytics, AI/ML collaboration platforms, and HPC-driven simulation partnerships to accelerate drug development and manufacturing simulations.

Patient Engagement A focus on defeating chronic diseases and improving accessibility opens doors for digital health engagement tools, patient adherence programs, and telehealth-enabled patient support partnerships to expand impact and adherence.